| Literature DB >> 36009286 |
Suzan Attia Mawed1, Carlotta Marini2, Mahmoud Alagawany3, Mayada R Farag4, Rasha M Reda5, Mohamed T El-Saadony6, Walaa M Elhady4, Gian E Magi2, Alessandro Di Cerbo2, Wafaa G El-Nagar1.
Abstract
In vertebrates, the core mechanisms that control gametogenesis are largely multiple, complex, successive, and orchestrated by intrinsic and extrinsic factors. However, age, health status, and hormonal activity are important factors for good fertility; other intangible intracellular molecular mechanisms that manage oocyte development are still unclear. The present study was designed to elucidate the ultrastructure changes in the ovary in response to its exposure to zinc oxide nanoparticles (ZnO-NPs) and to explore the role of autophagy and apoptosis during egg maturation and ovulation on the fertility of female zebrafish. In our study, ZnO-NPs could induce cytotoxicity in the maturing oocyte by activating autophagy and apoptosis in a caspase-dependent manner and could induce oxidative stress by generating reactive oxygen species (ROS) that elevated the mutated ovarian tP53 protein. Simultaneously, necroptosis developed, mimicking the features of apoptosis and necrosis. Collectively, ZnO-NPs created a suitable necrotic environment that led to follicular developmental retardation that altered oocyte ovulation and reduced fecundity of female zebrafish.Entities:
Keywords: apoptosis; autophagy; ovary; oxidative stress; zebrafish; zinc oxide nanoparticles
Year: 2022 PMID: 36009286 PMCID: PMC9404823 DOI: 10.3390/antiox11081567
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Target genes, accession number, and primer sequences for quantitative real-time PCR (qRT-PCR).
| Target Gene | Accession Number in NCBI | Primer Sequences |
|---|---|---|
|
| ||
| βactin | NM_131031 | F: 5′ ATGGATGAGGAAATCGCTGC 3′ |
| R:5′CTTTCTGTCCCATGCCAACC 3′ | ||
|
| ||
| Superoxide dismutase1 ( | NM_131294 | F: 5′ CGCACTTCAACCCTCATGAC 3′ |
| R: 5′ TGAATCACCATGGTCCTCCC 3′ | ||
| Superoxide dismutase2 ( | NM_199976 | F:5′CCTCCAGACAGAAGCA 3′ |
| R:5′CTGAAATGAGCCAAAGT 3′ | ||
| Glutathione peroxidase 1a ( | NM_001007281 | F:5′GCACAACAGTCAGGGAT 3′ |
| R:5′TCAGGAACGCAAACAG 3′ | ||
| Glutathione S-transferase pi 1.2 ( | NM_131734 | F:5′CCAACCACCTCAAATGCT 3′ |
| R:5′ACGGGAAAGAGTCCAGACAG 3′ | ||
| Catalase ( | NM_130912 | F:5′TGTGGAAGGAGGGTCG 3′ |
| R:5′CTTTGGCTTTGGAGTAG 3′ | ||
|
| ||
| Autophagy-related gene-7 homolog ( | XM 021479676 | F:5′ACGGTGATGCTGTTGGTCTG 3′ |
| R: 5′ TTTGTCGGTGGATTTGAAGG 3′ | ||
| Autophagy-related gene-5 homolog ( | NM_205618 | F: 5′ TGGAGTATCCCACCGAAGA3′ |
| R:5′ CACTGGTCGGAAGAGC3′ | ||
| Autophagy-related gene-12 homolog ( | NM_001246200 | F: 5′ TCATCTCACGCTTCCTCAA 3′ |
| R: 5′ TCACTTCCGAAACACTCAAA 3′ | ||
| Sequestosome 1 (sqstm1) ( | NM_001312913 | F: 5′ TGGTGCTACTGCCTCTTCTCA 3′ |
| R: 5′ GGGTTACTTTGGTCCGCTTT 3′ | ||
|
| ||
| Apoptosis-inducing factor ( | NM_001327928 | F: 5′ CCGCTACCGACAGGAGATCTACGA 3′ |
| R: 5′ GGTGTGGAGCGCGCTCTGTGCAGT 3′ | ||
| BCL2 associated X, apoptosis regulator ( | NM_131562 | F: 5′ GACAGGGATGCTGAAGTGA 3′ |
| R: 5′ TGAGTCGGCTGAAGATTAGA 3′ | ||
| Caspase a ( | NM_131505 | F: 5′ GACGGTGAGCCTGATGAGCCAA 3′ |
| R: 5′ CCTGAACAGTTCCTCGATGTGA 3′ | ||
|
| ||
| Methyltransferase like 3 ( | NM_212780 | F: 5′ CCTAGAGCTGCTGAATACCAGT 3′ |
| R: 5′ GATGATTCGCCTGAAGTGC 3′ | ||
| Progesterone receptor membrane component-1 ( | NM_001007392 | F: 5′ CAGACTATGGCCCGGTTGAGGAG 3′ |
| R: 5′ CTGCATGGCATTGAGATCGG 3′ | ||
| Zygote arrest 1 ( | NM_194381 | F: 5′ CAACCCGAAGACCGAC 3′ |
| R: 5′ CACCACCGCTGCTGAC 3′ | ||
| Gonadal soma-derived factor variant 2 ( | NM_001114668 | F: 5′ GCTCCATCCGTCACCT 3′ |
| R: 5′ TCACCGTAGACAGAACCAG 3′ | ||
| SRY-box transcription factor 3 ( | NM_001001811 | F: 5′ ATTCCGCAGTCCAACA 3′ |
| R: 5′ TTCTCCTGAGCCATCTTC 3′ | ||
|
| ||
| Metallopeptidase with thrombospondin type 1 motif, 15a ( | NM_001126429 | F:5′GAGAGCAAAGATAACAAGGCACAAA3′ |
| R: 5′TTTTCCACCTTTATTGACTCCACCT3′ | ||
| Luteinizing hormone/choriogonadotropin receptor ( | NM_205625 | F: 5′ CGCTCTGATCAACTGGGACA 3′ |
| R: 5′ GGCGCTGTTGGCATAAATCC 3′ | ||
| Progesterone receptor ( | NM_001166335 | F: 5′ ACAGACAGCATACACCGC3′ |
| R: 5′TCCACAGGTCAGAACTCC3′ | ||
| Follicle-stimulating hormone receptor (fshr) | NM_001001812 | F: 5′ CAAATGCGTCTACGCCATGC3′ |
| R: 5′AAAGCGGGATTACGGACGGT3′ | ||
| Follistatin a ( | NM_131037 | F: 5′ CATCAAGGCCAAGTCATGCG3′ |
| R: 5′GCCTGCTTCATGGCACACTC3′ | ||
Figure 1ZnO-NPs characterization: (A) shows the UV–VIS spectroscopy analysis of ZnO-NPs to estimate their optical properties; the maximum peak was 340 nm. (B) The size and shape of the ZnO-NPs were spherical with an average size of 108 nm by TEM. (C) DLS analysis showed that the exact size was 89 nm. (D) Zeta potential analysis showed that the net surface charge of ZnO-NPs was −33 mV.
Figure 2Effects of ZnO-NPs on Gonadosomatic index, fertility, and fecundity: (A) Representative pictures of the control, T1, and T2 females with normal ovaries in the control fish (a,d), transition state of malignancy in T1 (b,e), and ovarian necrosis in T2 (c,f) (Black asterisks). (B) Percentage of females with macroscopic ovarian malignancy for each experimental group (n = 10). (C) Distribution of gonad somatic index (GSI); notice the weight reduction of T2 females compared with the control. (D) Fertility assessment of the control, T1, and T2 groups declined at 30 dpt in T2 into 10%. (E) Tracing assessment of fecundity in the control, T1, and T2 with a significant reduction in T2 at 30 dpt. L: liver, O: ovary, S: spleen. The results are shown as the mean ± SEM. ** p < 0.01, *** p < 0.001. T1 = group was exposed to 1/5th of estimated LC50 of ZnO-NPs in water daily for two weeks (15 days). T2 = group was exposed to 1/5th of estimated LC50 of ZnO-NPs in water daily for one month (30 days).
Accumulation of ZnO-NPs residues in the whole body of treated female zebrafish (µg/g wet weight).
| Groups | Zn Residues |
|---|---|
| control | 15.83 ± 1.57 c |
| T1 | 32.10 ± 4.01 b |
| T2 | 57.85 ± 1.78 a |
| SEM | 6.26 |
| <0.001 |
Means within columns carrying different superscripts are significant at (p < 0.05). T1 = group was exposed to 1/5th of estimated LC50 of ZnO-NPs in water daily for two weeks (15 days). T2 = group was exposed to 1/5th of estimated LC50 of ZnO-NPs in water daily for one month (30 days).
Figure 3Histological structure showing the different stages of oocyte development in the control zebrafish ovary: (A) Primary growth stage (PGS) (blue arrow). (B) Cortical Alveolar Stage I (CASI) (red arrow). (C) Cortical Alveolar Stage II (CASII) (green arrow). (D) Vitellogenic Stage (VS) (yellow arrow). (E) Mature Stage (MS) (orange arrow). (F) Atretic Stage (AS) (black arrow). N: nucleus, Nu: nucleolus, Y: yolk, ZR: Zona radiata (H&E, 10 µm).
Figure 4Comparative histological observations of the control, T1, and T2 left and right ovaries (H&E, 25 µm): (A,B) Photomicrographs showing the left and right ovaries of the control; notice the presence of numerous mature oocytes (orange arrow). (C,D) Photomicrographs showing the left and right ovaries of T1; notice the presence of the primary growth stage (blue arrow), cortical alveolar stage II (green arrow), vitellogenic stage (yellow arrow), and the absence of the mature stage. (E,F) Photomicrographs showing the left and right ovaries of T2; notice the tissue degeneration (black asterisk) and the prominent distribution of primary oocytes (blue arrows). (G) Statistical analysis of ovary sections in the three experimental groups. Data are shown as the mean ± SEM. *** p < 0.001. T1 = group was exposed to 1/5th of estimated LC50 of ZnO-NPs in water daily for two weeks (15 days). T2 = group was exposed to 1/5th of estimated LC50 of ZnO-NPs in water daily for one month (30 days).
Figure 5Transmission Electron Microscopy observation of the control and T1 ovaries: (A–D) Transmission electron micrographs of the control vitellogenic oocyte showing the intact oocyte membrane with distinct cell layers of theca cells (ZT), granulosa cells (ZG), and zona radiata (ZR), large yolk granules, plenty of normal mitochondria, and a normal nucleus. (E–H) Transmission electron micrographs of the T1 ovary showing diffusion of ZnO-NPs to the ooplasm through the cell membrane (red arrows); notice the mild alteration of the cell membrane, mitochondrial degeneration, and chromatin condensation. OW: oocyte wall, ZT: Zona theca, ZG: Zona granulosa, ZR: Zona radiata, OP: ooplasm, Y: yolk, Mit: Mitochondria, Mic: microvilli, N: nucleus, Nu: nucleolus. T1 = group was exposed to 1/5th of the estimated LC50 of ZnO-NPs in water daily for two weeks (15 days).
Figure 6Transmission Electron Microscopy observation of T2 ovary: (A) Transmission electron micrographs of a primary oocyte (PGS) showing abnormal winding nuclear membrane (blue arrow) and cytoplasmic vocalizations (blue asterisks). (B–G) Micrographs of vitellogenic oocytes in abnormal conditions exhibited irregular cell walls with some vacuolization in the granulosa cell layer and the ooplasm (yellow arrow) with complete organelle degeneration (yellow arrow) due to the enormous diffusion of ZnO-NPs (red arrow). The nucleus appeared with a winding nuclear membrane (blue arrow) and the mitochondria exhibited atrophic cisternae and a swollen appearance (orange arrow). (H–L) Transmission electron micrographs showing the steps of autophagy; notice the presence of numerous autophagosomes (green arrow) and autolysosomes (white arrow). OW: oocyte wall, ZT: Zona theca, ZG: Zona granulosa, ZR: Zona radiata, N: nucleus, Mit: Mitochondria, PGS: primary growth stage, AP: autophagosome, AL: autolysosome.
Figure 7Effect of ZnO-NPs on oocyte maturation and ovulation via the induction of oxidative stress and the apoptotic pathway at the genetic level. (A–C) Expressions of mRNA evaluated by qRT-PCR indicate the downregulation of antioxidant-related genes in T2 (A), the upregulation of autophagy-related genes in T2 (B), and the induction of apoptosis-related genes in T2 (C). (D,E) mRNA expression shows the downregulation of oocyte maturation-related genes in T2 (D) and ovulation genes in T2 (E). The results from three dependent experiments are shown as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. T1 = group was exposed to 1/5th of the estimated LC50 of ZnO-NPs in water daily for two weeks (15 days). T2 = group was exposed to 1/5th of the estimated LC50 of ZnO-NPs in water daily for one month (30 days).
Figure 8Effect of ZnO-NPs on necroptosis via mutated tP53 formation: (A) Western blot analysis of the tP53 protein, Vasa protein, and Pgr protein normalized to β-actin in control, T1, and T2 groups. (B) Western blot analysis of procaspase-3 and cleaved caspase-3 in the control, T1, and T2 groups revealed the overexpression of cleaved caspase-3 in T2 compared with the control and T1 groups. (C–F) Quantified protein expression revealed the ratio analysis of tP53/β-actin, Vasa/β-actin, Pgr/β-actin, and cleaved -cas3/pro-cas3, respectively quantified by the Image J software. Data expressed as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001. T1 = group was exposed to 1/5th of the estimated LC50 of ZnO-NPs in water daily for two weeks (15 days). T2 = group was exposed to 1/5th of the estimated LC50 of ZnO-NPs in water daily for one month (30 days).